Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Calgary, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange UNIVERSAL IBOGAINE INC. stocks are traded under the ticker JC4.
JC4 reached its all-time high on Apr 7, 2022 with the price of 0.0960 EUR, and its all-time low was 0.0005 EUR and was reached on May 17, 2023. View more price dynamics on JC4 chart. See other stocks reaching their highest and lowest prices.
JC4 net income for the last quarter is −586.92 K EUR, while the quarter before that showed −152.81 K EUR of net income which accounts for −284.08% change. Track more UNIVERSAL IBOGAINE INC. financial stats to get the full picture.
No, JC4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIVERSAL IBOGAINE INC. EBITDA is −326.66 K EUR, and current EBITDA margin is −170.36%. See more stats in UNIVERSAL IBOGAINE INC. financial statements.
Like other stocks, JC4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIVERSAL IBOGAINE INC. stock right from TradingView charts — choose your broker and connect to your account.